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Abstract
Background: To guide malaria elimination efforts in Swaziland and other countries, accurate assessments of transmission
are critical. Pooled-PCR has potential to efficiently improve sensitivity to detect infections; serology may clarify temporal and
spatial trends in exposure.
Methodology/Principal Findings: Using a stratified two-stage cluster, cross-sectional design, subjects were recruited from
the malaria endemic region of Swaziland. Blood was collected for rapid diagnostic testing (RDT), pooled PCR, and ELISA
detecting antibodies to Plasmodium falciparum surface antigens. Of 4330 participants tested, three were RDT-positive yet
false positives by PCR. Pooled PCR led to the identification of one P. falciparum and one P. malariae infection among RDT-
negative participants. The P. falciparum-infected participant reported recent travel to Mozambique. Compared to
performing individual testing on thousands of samples, PCR pooling reduced labor and consumable costs by 95.5%.
Seropositivity was associated with age $20 years (11?7% vs 1?9%, P,0.001), recent travel to Mozambique (OR 4.4 [95% CI
1.0–19.0]) and residence in southeast Swaziland (RR 3.78, P,0.001).
Conclusions: The prevalence of malaria infection and recent exposure in Swaziland are extremely low, suggesting
elimination is feasible. Future efforts should address imported malaria and target remaining foci of transmission. Pooled PCR
and ELISA are valuable surveillance tools for guiding elimination efforts.
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Introduction
Global progress in malaria control has led to increased interest in
and optimism for elimination. Of 99 countries that remain endemic,
32 are moving towards elimination, including four in sub-Saharan
Africa [1]. To guide planning, improved diagnostic and surveillance
strategies specific to low endemic settings are needed to track
progress and identify residual foci of transmission [2,3].
The burden of malaria is typically estimated by passive and
active surveillance. Passive surveillance generally involves health
facility based reporting of malaria cases, which can be limited by
incomplete reporting, healthcare seeking in the private sector, and
poor diagnostic capacity, particularly in low transmission settings
where health workers see few malaria cases. Active surveillance
addresses some of these limitations and generally involves cross-
sectional surveys of defined sample populations, where the primary
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malaria indicator is the proportion of persons infected with
malaria parasites (parasite prevalence) [4]. These surveys enable
detection of asymptomatic infections that perpetuate transmission
[5] and provide an opportunity to concurrently assess coverage of
malaria interventions [6].
Estimating parasite prevalence typically relies on microscopy,
which is time and labor intensive, and often inaccurate in
operational settings [7,8]. Newly available rapid diagnostic tests
(RDTs) offer ease of use and timely results, but have limitations in
specificity, sensitivity, quality, and cost [8]. PCR provides
enhanced sensitivity but results are not available immediately.
Additionally, when prevalence is low, high costs and labor may
render individual testing of every sample impractical. However, a
novel pooled method offers the opportunity for efficient, sensitive,
and specific testing [9]. Lastly, serology to detect antimalarial
antibodies, as a unique measurement of past infection, may help to
delineate temporal and spatial trends in transmission [10,11].
Moreover, in previous elimination programs, absence of antibody
responses in certain age groups has been used as evidence of the
cessation of transmission [12].
Swaziland is a country in southern Africa that has experienced
recent declines in malaria burden [13]. From 1999 to 2010,
annual laboratory-confirmed malaria cases decreased from 4005
to 196 (3.8 to 0.2 per 1000 population), and suspected or non-
laboratory confirmed cases decreased from 29,374 to 3470 (27.7 to
2.9 per 1000 population) [14,15]. These declines have been
attributed to annual indoor residual spraying (IRS) and a cross-
border program that has successfully decreased malaria transmis-
sion in neighboring southern Mozambique and South Africa [13].
In 2007, the Ministry of Health with support from regional leaders
[16,17] launched a goal to eliminate malaria by 2015 [18]. To
evaluate the impact of the current program, and guide planning
for malaria elimination, a national Malaria Indicator Survey (MIS)
[6] was conducted for the first time in Swaziland’s history.
Intervention coverage was assessed and parasitemia was measured
by RDT instead of microscopy. Novel surveillance techniques
using dried blood spots included pooled PCR, to more accurately
estimate parasite prevalence, and serology to estimate past
exposure to parasites.
Results
Survey demographics and intervention coverage
5613 participants living in 1751 households were surveyed.
Most participants lived in urban areas (53.3%), and in the eastern
region of Lubombo (79.2%). Twelve percent of participants
reported international travel in 2010, with South Africa (84.3%)
and Mozambique (14.4%) being the most frequent destinations.
Most participants resided in their current residence for .3 years
(76.1%) (Table 1).
Indoor residual spraying (IRS) in the past 12 months was
reported in 44.5% of households. Bed net use was low: 3.6% of
participants reported sleeping under an ITN the previous night.
Among children and women who sought care for fever in the last
two weeks, 0% and 15.4%, respectively, received a finger or heel
stick for malaria diagnosis (Table 2). Among 46 participants (0.9%)
that reported receiving an antimalarial in the previous 2 weeks,
none reported receiving an artemsinin-based combination thera-
py, the recommended first-line treatment.
RDT and PCR results
RDTs were performed in 4330 of 5613 (77%) participants and
three were positive for P. falciparum (Figure 1). By PCR, these were
negative in duplicate and therefore considered false positives. 4028
dried blood spots from RDT-negative participants were tested by
PCR using the three-stage pooling strategy. Two infections were
identified, one P. falciparum in a 57 year-old man, and one P.
malariae in a 46 year-old woman. Both resided in the northeast
region of Swaziland, near the Mozambique border (Figure 2).
Neither reported having a fever in the two last weeks, though the
P. falciparum-infected participant reported recent travel to Maputo,
Mozambique. Based on PCR results, weighted parasite prevalence
was estimated at 0.2% (95% CI 0.0–0.6). Using PCR as the gold
standard, RDTs identified none of the two PCR positive samples
resulting in a sensitivity of 0.0%, specificity of 99.9%, positive
predictive value of 0%, and negative predictive value of 100%.
Cost and operational comparisons between different
methods used to identify infection
Using a pooled strategy for PCR, a total of 182 assays were
performed to test the 4028 dried blood spots (Figure 1). Compared
to performing individual PCR on all samples, use of pooling
reduced labor and consumable costs by 95.5%.
Cost and other operational issues were considered in a
comparison amongst RDT, microscopy, individual PCR, and
pooled PCR (Table 3). Cost to assay all samples was most
expensive by individual PCR and RDT (.$6000 USD). Pooled
PCR had the highest facility, equipment, and training needs, but
testing costs were the lowest ($291). Only RDT could be used as a
point of care test and thus guide treatment during the survey.
Turnaround time was on the order of weeks for microscopy and
individual PCR, and on the order of days for pooled PCR.
Serology results
1820 of 4031 participants with dried blood spots were sampled
for serology. Overall, 82 participants (5.8%, 95% CI 3.9–7.6) had
antibodies to both AMA-1 and MSP-142 antigens. There was a
step increase in seroprevalence at 20 years of age (Figure 3).
Compared to participants that were 20 to 49 years of age,
seroprevalence among participants one to 20 years of age was
Table 1. Baseline characteristics of survey participants.
Baseline characteristic No. (weighted %, 95% CI)
Male (n = 5613) 2721 (48.6%, 47.0–50.2)
Age category (n = 5611)
,10 years 1463 (24.7%, 23.3–26.1)
10–19 years 1221 (21.0%, 19.3–22.7)
$20 years 2929 (54.3%, 52.4–56.2)
Urban residence (n = 5613) 2186 (53.3%, 48.7–57.9)
Mean altitude, meters (n = 5557) 345.9 (325.4–366.4)
Region (n = 5613)
Hhohho 782 (10.2%, 5.0–15.3)
Lubombo 4054 (79.2%, 72.8–85.6)
Manzini 334 (4.2%, 1.0–7.3)
Shiselweni 443 (6.5%, 2.5–10.6)
Residence in current district (n = 5199)
,1 year 528 (11.2%, 9.7–12.7)
1–3 years 619 (12.7%, 11.4–14.1)
.3 years 4052 (76.1%, 74.0–78.1)
International travel in 2010 (n = 5199) 559 (11.6%, 9.9–13.3)
doi:10.1371/journal.pone.0029550.t001
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significantly lower (1.9% vs 11.7%, P,0.001). Exclusion of
participants who reported recent travel to Mozambique yielded
the same age-specific pattern of seroprevalence (data not shown).
Analysis of seroconversion rates suggested a significant change in
seroconversion rate 20.1 years ago (95% CI 18.8220.5),
suggesting a temporal change in malaria exposure in the year
1989.
There were no significant relationships between seropositivity
and wealth index, urban vs rural residence, altitude, IRS coverage,
or bed net use. Reported travel to Mozambique, but not South
Africa, within 2010 was significantly associated with seropositivity
(OR 4.4, 95% CI, 1.0–19.0, P=0.048).
Spatial cluster analysis was performed to identify areas with
higher than expected seroprevalence. A primary cluster was
identified in the southeast region of the country (RR for
seropositivity 3.8, P,0.001). Two secondary clusters of higher
relative risk were identified within the primary cluster: one
extending from Sithobela to Somntongo constituency (RR 5.0,
P,0.001) and a smaller one limited to Somntongo (RR 6.4,
P=0.002) (Figure 2). To assess whether clusters of seropositivity
reflected only distant exposure, the same analyses were performed
among participants less than ten years of age. Similar clusters were
identified: the primary cluster extended from Sithobela to
Somntongo (RR 5.2, P=0.02) and a secondary cluster was
located in Somntongo (RR 6.9, P=0.03). Analyses examining
responses to individual antigens or either antigen showed similar
clustering (data not shown). Analysis excluding participants with
reported recent travel to Mozambique yielded the same three
clusters.
Discussion
To guide strategic planning for the transition from malaria
control to elimination, we utilized novel malaria surveillance
techniques of pooled PCR and serology to perform the first large
scale cross-sectional malaria survey in Swaziland and found that
prevalence of infection and recent exposure was extremely low. By
pooled PCR, only one P. falciparum and one P. malariae infection
were identified among 4028 participants. Compared to RDT,
pooled PCR identified infections missed by RDT and provided
improved efficiency and affordability excluding capital costs.
Serological data identified a potential focus of recent transmission
in the southeast and low seroprevalence in younger age groups,
suggesting low exposure to malaria in recent years. Report of
recent travel to Mozambique was identified as a risk factor for
both P. falciparum infection and seropositivity.
Large-scale prevalence surveys have traditionally relied on
microscopy, but considering the significant time and labor
required, and potential operational limitations, the Swaziland
malaria program decided to use RDTs. As a simple point-of-care
test, RDTs are convenient, but can give false positive results with
underlying autoimmune conditions, non-malarial infections, or
persistence of the P. falciparum HRP-2 antigen despite resolution of
infection [19]. Pooled PCR is extremely specific, 100%, because
repeat testing of the sample at each stage limits DNA
contamination [9]. Using pooled PCR as gold standard, there
were three false positives by RDT in our study, and due to the
extremely low prevalence, positive predictive value was poor. With
large-scale surveys in higher prevalence settings, RDT have also
had low positive predictive value [20].
RDTs may also miss infections of low parasite density and many
do not detect non-falciparum species [8]. In our study, the P.
falciparum-specific RDT missed one P. malariae infection, and one P.
falciparum infection that was likely of low parasite density given that
the participant was afebrile. Others have found low parasite
density to be a determinant of decreased sensitivity in survey
settings [21]. The detection limit of current RDTs is 100–200
parasites/mL. The detection limit of pooled PCR can reach
submicroscopic levels but sensitivity is only reliable at 100
parasites/mL [9]. It is possible that the three RDT positives were
true infections missed by pooled PCR. As an antigen-based assay,
RDT could potentially be more sensitive if there is sequestering of
P. falciparum parasites, particularly in low density infections. These
subjects could have also had a recent infection that cleared, but
persistent antigenemia. While not assessed in this study, micros-
copy and individual PCR are more sensitive than pooled PCR [9].
However, the efficiency provided by pooled PCR, and potential
Table 2. Intervention coverage among of survey participants.
Intervention No. (weighted %, 95% CI)
Vector control
Household sprayed in the past 12 months (n = 1751) 773 (44.5%, 40.3–48.6)
Household with at least 1 insecticide treated bed net (ITN) (n = 1751) 301 (16.6%, 14.1–19.1)
Household with at least 1 ITN and/or sprayed in last 12 months (n = 1751) 926 (53.2%, 49.4–57.0)
Slept under an ITN the previous night, all participants (n = 5613) 176 (3.6%, 2.5–4.6)
Slept under an ITN the previous night, children ,5 years (n = 766) 41 (5.8%, 3.3–8.4)
Slept under an ITN the previous night, women (n = 1296) 49 (3.8%, 2.5–5.2)
Diagnostic/ treatment service
Diagnosed with malaria within the past 2 weeks (all participants, n = 5411) 45 (0.9%, 0.4–1.3)
Treated with an antimalarial drug in the past 2 weeks (all participants, n = 5411) 46 (0.9%, 0.5–1.4)
Children with fever in the last 2 weeks and sought care (n = 38)* 26 (67.4%, 51.6–83.1)
Children with fever in the last 2 weeks and received finger or heel stick (n = 38)* 0
Women with fever in the last 2 weeks and sought care (n = 45)** 22 (53.5%, 40.7–66.3)
Women with fever in the last 2 weeks and received a finger stick (n = 22)** 3 (15.4%, 0–33.9)
*Total number of children with fever in last 2 weeks (n = 362): 39 (12.5%, 95% CI 6.7–18.3%).
**Total number of women with fever in last 2 weeks (n = 961): 47 (4.7%, 95% CI 2.6–6.8%).
doi:10.1371/journal.pone.0029550.t002
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for improved sensitivity over RDT, suggest that for large-scale
surveys among asymptomatic populations in low prevalence
settings, pooled PCR may be preferred. Compared to performing
individual PCR testing, use of pooling in this study reduced labor
and consumable costs for PCR by greater than 95%.
One limitation with measuring parasitemia in a cross-sectional
survey is that regardless of the sensitivity of the test, only one
moment in time is captured. In low endemic settings such as
Swaziland, prevalence may be so low that it will be difficult to
track progress toward elimination. As a measure of past infection,
serology has been proposed as a useful way to estimate exposure in
low endemic settings [2,10,22]. In our study, a statistically
significant difference in seroprevalence and seroconversion rate
among participants less than 20 years of age compared to older
participants suggests a significant decrease in transmission in 1989,
with low stable levels of transmission since that time [23].
Declining incidence in Swaziland over the past 20 years is
consistent with this finding [14,15,24].
Serological data may additionally help to identify other
epidemiological risk factors for malaria. Travel to Mozambique
and residence in the southeastern region were found to be
associated with seropositivity. The first finding is consistent with
Swaziland’s passive surveillance and case investigation data, which
have found travel to Mozambique to be a risk factor for infection
[25]. The second finding was unexpected as incidence in the
southeastern region of the country has been low in recent years
[25]. However, there are many sugar plantations in this area and
migrant workers from Mozambique may be a source of
transmission. Our data did not include information on occupation
or nationality, but suggest that detailed, focal investigation of this
region is indicated to determine if seropositivity represents past
infection acquired in Mozambique or local transmission.
One potential limitation in our study is that cutoff for
seropositivity was based on an assumption of a bi-modal distribution
of seropositives and seronegatives within the population sampled.
Samples from representative seronegatives (e.g. age- and genetically-
matched participants from Swaziland with no history of falciparum
exposure but similar exposure to other infections that could result in
cross-reactive antibodies) were not available and in practice may be
difficult to obtain. Our data suggest a clear temporal trend of a
decline in malaria transmission 20 years prior. However, the
potential non-specific response seen among younger age groups may
suggest that this method is not specific enough to show cessation of
transmission, as has been shown in other settings [12]. To enable
more accurate estimates of further decrease in transmission using
serology, longitudinal studies are needed to better characterize the
development, maintenance, and decay of specific antibodies [22].
Findings of this study have important implications on Swazi-
land’s strategic planning for malaria elimination. First, the findings
of extremely low parasite prevalence and recent exposure suggest
that the high IRS coverage (45% compared to other parts of
Africa, where IRS coverage is approximately 10% [15]) and the
cross-border collaboration with Mozambique and South Africa
have been effective and should be continued. Second, low
transmission in spite of low ITN use suggests that further
investment into this costly program may not be justified. Rather,
ITNs could be reserved for use in identified hot spots and high-risk
groups. Third, limited access to diagnostic and treatment services
among febrile participants identified passive surveillance and case
management as an area for improvement. Finally, future efforts
should aim to prevent imported malaria and investigate and target
interventions to limited foci of transmission.
For low transmission countries aiming to eliminate malaria,
reliance on microscopy or RDT for active surveillance may be
inadequate. We document the first national survey from an
elimination setting to show that pooled PCR and serology, as
accurate and efficient methods to measure current and past
infection, can provide critical data to inform strategic planning.
Additionally, renewed interest in elimination has been accompa-
nied by skepticism about the feasibility of elimination, particularly
in sub-Saharan Africa [26]. This study documents an extremely
low prevalence of malaria infection and recent exposure in
Swaziland, providing evidence-based optimism for efforts in
Swaziland and the region.
Figure 1. Participant recruitment and results for testing by RDT
and pooled-PCR. DBS, dried blood spots.
doi:10.1371/journal.pone.0029550.g001
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Materials and Methods
Objectives
We aimed to measure and describe the burden of malaria in
Swaziland as relevant to planning for malaria elimination. We
hypothesized that compared to using RDT, use of pooled-PCR
and serology would improve sensitivity and efficiency for detection
of infections and use of serology would clarify temporal and spatial
trends in exposure.
Participants
The historically malaria endemic eastern part of the country
was included. Based on the ecological and administrative
subdivisions of the country, census enumeration areas (EAs) were
arranged into four strata. Of 598 EAs, 172 were randomly selected
based on probabilities proportional to population size. Geo-
coordinates of all households within selected EAs were recorded
[27,28]. Initially, 15 households were randomly selected within
each EA; due to time and budget constraints, ten households were
targeted as the study progressed.
Procedures
An MIS with a stratified two-stage cluster sample, cross-
sectional design was used to generate representative estimates of
intervention coverage and malaria disease burden. Given Swazi-
land’s goal of elimination, several modifications were made to the
traditional MIS design [6]. Intervention coverage and parasite
prevalence were assessed in all age groups, not just children less
than five years of age and women of reproductive age. Additional
questions about travel in 2010 and residence were included, and
microscopy and hemoglobin testing were excluded in favor of
RDT, pooled PCR, and serology. Data and sample collection took
place April to May of 2010, near the end of the annual high
transmission season. A household questionnaire was administered
to the household head or other consenting adult. A women’s
questionnaire was administered to women 15 to 49 years of age.
Parasite Detection
A single finger prick was performed to collect blood for RDT
(First Response Malaria Ag P. falciparum HRP2 Detection Rapid
Card Test, Premier Medical Corporation Ltd) and Whatman 903
Figure 2. Map of Swaziland with RDT or PCR-positive participants and potential hot spots identified in serologic cluster analysis.
doi:10.1371/journal.pone.0029550.g002
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filter paper. Participants testing positive by RDT were transported
to the nearest health facility for care.
Blood spots were dried for at least three hours and stored in
individual plastic bags with desiccant at ambient temperature.
They were transferred to 4uC within one week and to 220uC
within one month. In duplicate, dried blood spots from RDT-
positive participants were individually chelex extracted then tested
by PCR using nested PCR targeting the cytochrome b gene [9].
Pooled PCR Methods
Samples from RDT-negative participants were tested using a
three-stage PCR-based pooling strategy as previously described
[9,29]. Briefly, samples were first tested in master pools of 25.
Positive master pools were divided and tested into sub pools of five,
with positive sub pools tested as individual samples. At each stage,
DNA was chelex extracted from pooled or individual dried blood
spots, and then tested using nested PCR targeting the cytochrome b
gene. In pooled stages, controls reflected the test pool size, e.g.
controls for the master pool stage consisted of one punch from a
laboratory generated dried blood spot (parasite density 100
parasites/mL) mixed with 24 negative spots. To determine species,
PCR-positive samples underwent an AluI restriction digestion and
were compared to digestion patterns of known controls [30].
Serology sampling and testing
A sub-sample of all participants with a dried blood spot was
selected for serologic testing. Those less than one year of age were
excluded due to potential persistence of maternal antibodies. All
participants one to nine years of age were included because results
in this age group were expected to be most reflective of recent
changes in transmission. Based on reported declines in incidence,
age-stratified analyses were expected to be powered by a lower
seroprevalence in younger age groups. Therefore, participants ten
to 49 years of age were randomly sampled by district based on the
maximum number of participants in the younger age categories.
Participants 50 years of age and older were excluded.
ELISA Methods
ELISA assays were performed similarly to previously described
methods [31]. A 3 mm punch was excised from the dried blood
spot and antibodies were eluted overnight in 240 mL phosphate
buffered saline with 0.05% Tween 20 (PBS-T), which was also
used for all washing steps. Elutes were assayed in duplicate for
antibodies against Plasmodium falciparum FVO strain blood stage
antigens merozoite surface protein-1 (MSP-142), and apical
membrane antigen-1 (AMA-1), provided by Walter Reed Army
Institute of Research [32]. High absorbance plates (Immulon
4HX) were coated with 75 mL of antigen at 0.5 mg/mL overnight.
Plates were washed and then blocked using 150 mL of 5% Blotto,
non-fat milk in phosphate buffered saline. After washing, plates
were incubated with 75 mL of elutes as well as titrations of pooled
serum from previously infected participants in Kampala, Uganda.
After another washing step using PBS-T, plates were incubated
Table 3. Cost and operational comparisons between infection diagnostic methods.
Cost or Operational Issue RDT Microscopy PCR
Cost per sample* $1.50 $0.26 $1.55
Cost for all 4031 samples* $6047 $1048 $6248 (individual PCR)
$291 (pooled PCR)
Detection limit** 100 to 200 p/mL 4 to 100 p/mL ,4 p/mL (individual PCR) 100 p/mL
(pooled PCR)
Point-of-care test Yes Only if basic laboratory services available Not practical
Capital equipment None Microscope PCR machine
Training Minimal Moderate Extensive
Turnaround time per sample 15 minutes 30 minutes 2 days
Turnaround time for all 4031 samples n/a Weeks Weeks (individual PCR)
Days (pooled PCR)
p/mL =parasites/mL.
*Costs presented in US$ and do not include personnel. Estimates for microscopy were approximated based on published figures [8], and estimates for RDT and PCR
were gathered from this study.
**Estimates based on published figures [8,9,22]. Detection limit for pooled PCR based on use of a 100 parasites/mL sample as control in this study. However, it should be
noted that detection limit ,4 parasite/mL for pooled PCR is possible as previously reported [9].
doi:10.1371/journal.pone.0029550.t003
Figure 3. Seroprevalence to P. falciparum antigens MSP-142 and
AMA-1 by age categorywith 95% confidence interval half-widths.
doi:10.1371/journal.pone.0029550.g003
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with 75 mL of antihuman IgG antibody (AP-conjugated AffiniPure
Goat Anti-Human IgG, Jackson Immunoresearch). After a final
washing step, 75 mL of substrate (BluePhos Microwell Phosphatase
Substrate System, KPL) was added and optical density detected
using Versamax ELISA reader (Molecular Diagnostics).
Data management and statistical analyses
The sample size was generated to provide an estimate of
insecticide-treated bed net (ITN) use in children less than five years
of age. Based on previous surveys, response rate and design effect
were estimated at 90% and 1.3, respectively, allowing for a
sampling error of 12% [33]. With the average number of children
under five per household being 0.13, 2500 households were
targeted.
Survey data were entered into personal digital assistants (PDAs)
and downloaded into Microsoft Access (2007). Analyses were
performed using SAS (version 9.2) and STATA (version 11.0).
Point estimates and confidence intervals were calculated incorpo-
rating survey procedures and weights to adjust for multi-stage
clustering and changing selection probability.
For serologic analyses, raw optical densities were standardized
by dividing values by a positive control on all plates. Samples with
a coefficient of variation .0.3 between duplicates were repeated.
To determine seropositivity cutoffs for each antigen, standardized
optical densities were fitted to a mixture model that assumed a bi-
modal normal distribution, and seropositivity was defined as three
standard deviations above the mean of the lower distribution [31].
Due to the potential for false positive responses to a single antigen,
seropositivity was defined as presence of antibodies to both AMA-
1 and MSP-142.
Evidence for temporal changes in exposure was explored by
assessing the relationship between age and seroprevalence. To
formally assess a temporal change in exposure, a catalytic
conversion model assessing seroconversion rate was fitted to the
data, allowing for a change in the seroconversion rate at a single
time-point. The time point at which a change in seroconversion
occurred was assessed by maximum likelihood with confidence
intervals based on the chi-squared distribution on one degree of
freedom [23].
To analyze relationships between seropositivity and baseline
characteristics, chi-squared, t-test, logistic regression, or two-
sample test of proportions was performed as appropriate. P-values
less than .05 were considered statistically significant. To identify
potential foci of transmission, spatial cluster analysis was
performed with SatScan (version 9.0), using the Poisson model
and allowing for elliptical clusters. Due to sampling among
participants ten to 49 years of age, age was adjusted for as a
categorical variable (,10 years, 10-19 years, $20 years).
Maximum geographical cluster size was set at 50% of the
population, allowing for nested clusters. Statistically significant
clusters were reported, including nested clusters with a relative risk
greater than that of the parent cluster. Maps were produced using
ArcGIS software (version 10.0).
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